First Analysis Weighs in on Health Insurance Innovations, Inc.’s FY2017 Earnings (NASDAQ:HIIQ)
Health Insurance Innovations, Inc. (NASDAQ:HIIQ) – First Analysis increased their FY2017 EPS estimates for Health Insurance Innovations in a research note issued to investors on Sunday. First Analysis analyst now expects that the financial services provider will post earnings of $1.65 per share for the year, up from their previous forecast of $1.44. First Analysis also issued estimates for Health Insurance Innovations’ Q1 2018 earnings at $0.41 EPS, Q2 2018 earnings at $0.54 EPS and FY2018 earnings at $2.02 EPS.
Several other research analysts have also recently commented on HIIQ. Zacks Investment Research cut Health Insurance Innovations from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 3rd. UBS AG raised Health Insurance Innovations to an “outperform” rating in a research report on Thursday, May 4th. Raymond James Financial, Inc. raised Health Insurance Innovations from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research report on Thursday, May 4th. TheStreet raised Health Insurance Innovations from a “c” rating to a “b-” rating in a research report on Monday, May 22nd. Finally, Craig Hallum started coverage on Health Insurance Innovations in a research report on Monday, June 12th. They issued a “buy” rating and a $28.00 target price for the company. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $30.83.
COPYRIGHT VIOLATION NOTICE: “First Analysis Weighs in on Health Insurance Innovations, Inc.’s FY2017 Earnings (NASDAQ:HIIQ)” was published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.americanbankingnews.com/2017/08/08/first-analysis-weighs-in-on-health-insurance-innovations-inc-s-fy2017-earnings-nasdaqhiiq.html.
Shares of Health Insurance Innovations (NASDAQ:HIIQ) opened at 32.25 on Tuesday. The company has a market cap of $372.49 million, a price-to-earnings ratio of 26.09 and a beta of 0.68. Health Insurance Innovations has a 1-year low of $3.90 and a 1-year high of $32.55. The firm’s 50-day moving average is $25.25 and its 200 day moving average is $20.08.
Health Insurance Innovations (NASDAQ:HIIQ) last released its earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.13. Health Insurance Innovations had a net margin of 5.56% and a return on equity of 23.92%. The firm had revenue of $61.80 million during the quarter, compared to analyst estimates of $53.69 million. The business’s revenue was up 38.9% on a year-over-year basis.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Tudor Investment Corp ET AL bought a new position in Health Insurance Innovations during the first quarter valued at about $648,000. Dialectic Capital Management LP raised its position in Health Insurance Innovations by 39.7% in the first quarter. Dialectic Capital Management LP now owns 496,300 shares of the financial services provider’s stock valued at $7,941,000 after buying an additional 141,083 shares in the last quarter. Menta Capital LLC bought a new position in Health Insurance Innovations during the first quarter valued at about $909,000. Renaissance Technologies LLC raised its position in Health Insurance Innovations by 1,031.7% in the fourth quarter. Renaissance Technologies LLC now owns 213,900 shares of the financial services provider’s stock valued at $3,818,000 after buying an additional 195,000 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust bought a new position in Health Insurance Innovations during the first quarter valued at about $6,383,000. Hedge funds and other institutional investors own 72.13% of the company’s stock.
In other Health Insurance Innovations news, insider Sheldon Wang sold 12,417 shares of the stock in a transaction on Friday, May 12th. The stock was sold at an average price of $21.18, for a total transaction of $262,992.06. Following the completion of the transaction, the insider now directly owns 226,251 shares in the company, valued at $4,791,996.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Bruce Telkamp sold 24,179 shares of the stock in a transaction on Wednesday, May 10th. The stock was sold at an average price of $20.25, for a total value of $489,624.75. Following the transaction, the chief executive officer now owns 116,501 shares of the company’s stock, valued at $2,359,145.25. The disclosure for this sale can be found here. Insiders have sold 241,983 shares of company stock valued at $5,978,345 over the last quarter. Corporate insiders own 30.00% of the company’s stock.
About Health Insurance Innovations
Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.
Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.